Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

Clinical trial NCT06894797 · RECRUITING

Trial details

NCT number: NCT06894797
Sponsor: Peking University Cancer Hospital & Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Locally Advanced Rectal Cancer

Start date: 2025-04-01
Primary completion: 2026-10-31
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.